Status:
COMPLETED
Subscapularis Strength After Total Shoulder Arthroplasty
Lead Sponsor:
Henry Ford Health System
Conditions:
Shoulder Osteoarthritis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This is a randomized, double-blinded, standard of care-controlled clinical trial. The purpose of this study is to determine the difference in subscapularis strength and function after anatomic Total S...
Detailed Description
Study Design: This is a randomized, double-blinded, standard of care-controlled clinical trial. All adult patients undergoing anatomic total shoulder arthroplasty for glenohumeral osteoarthritis will ...
Eligibility Criteria
Inclusion
- All adult patients over the age of 18
- Must have a diagnosis of glenohumeral osteoarthritis
- Must be scheduled for primary anatomic total shoulder arthroplasty.
Exclusion
- History of prior rotator cuff surgery
- Rotator cuff deficiency
- Planned reverse total shoulder arthroplasty
- inflammatory arthropathy
- prior shoulder replacement surgery
- neurologic deficits of the affected extremity
- diagnosis of frozen shoulder
- previous infection in the shoulder.
Key Trial Info
Start Date :
October 2 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 31 2022
Estimated Enrollment :
66 Patients enrolled
Trial Details
Trial ID
NCT03854357
Start Date
October 2 2018
End Date
March 31 2022
Last Update
November 4 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Henry Ford Health Systems
Detroit, Michigan, United States, 48202